Conaris Research Institute AG - Company Review
Conaris Research Institute AG - Company ReviewSummary
Conaris Research Institute AG (Conaris) is a biotechnological company that provides preclinical and early clinical development services. The company provides drugs for various inflammatory indications. Its pipeline product candidates include FE999301, CR12/01, CR12/02, CR13/01, CR15/01 and conaskin tinktur. Conaris develops fusion protein, anti-inflammatory small molecule, gut microbiota modulator, and anti-infectious drug. The company’s activities comrpise development of new drugs, lead optimization, physical and chemical characterization, lab scale production and GMP development. It also develops in-house technology platform and a network of associated partners for the requirements of drug development candidates. Conaris is headquartered in Kiel, Germany.
This comprehensive company report of Conaris Research Institute AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.